SCHEMBL1619631

SCHEMBL1619631

CCOc1c(F)cccc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ L3MBTL1 Q9Y468 4/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ TUBB1 Q9H4B7 1/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ HTR2A P28223 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ GSK3A P49840 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ NFE2L2 Q16236 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ KAT6A Q92794 1/20 0.40
▸ HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1405871 0.88 L3MBTL1 (0.56) SMN1; SMN2L3MBTL1TDP1TUBB1KMT2A
SCHEMBL2518861 0.86 SMN1; SMN2 (0.68) SMN1; SMN2L3MBTL1KMT2AHTR2AHTR2C
SCHEMBL2035810 0.85 L3MBTL1 (0.53) SMN1; SMN2L3MBTL1TDP1TUBB1KMT2A
SCHEMBL1547887 0.83 L3MBTL1 (0.48) SMN1; SMN2L3MBTL1TDP1TUBB1KMT2A
SCHEMBL2525316 0.82 SMN1; SMN2 (0.63) SMN1; SMN2L3MBTL1TUBB1KMT2AHTR2A
SCHEMBL13617356 0.81 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1TDP1KMT2AMAPK1
SCHEMBL1627720 0.81 NFE2L2 (0.50) SMN1; SMN2L3MBTL1TDP1KMT2AMAPK1
SCHEMBL29669870 0.81 NFE2L2 (0.50) SMN1; SMN2L3MBTL1TDP1KMT2AMAPK1
SCHEMBL12093640 0.81 TUBB1 (0.49) L3MBTL1TDP1TUBB1KMT2AHTR2A
SCHEMBL12719865 0.80 L3MBTL1 (0.45) L3MBTL1TDP1ALDH1A1HTR1ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011064789-A1 IMPROVED PROCESS FOR THE PREPARATION OF HALO-DIALKOXYBENZENES HIKAL LIMITED (IN) 2011-06-03 — — WO disclosed
US-7928268-B2 Process for producing 1,2-dialkoxy-3-fluorobenzene ASAHI GLASS COMPANY, LIMITED (JP) 2011-04-19 — — US disclosed
US-20100286451-A1 Process for producing 1,2-dialkoxy-3-fluorobenzene ASAHI GLASS COMPANY, LIMITED 2010-11-11 — — US disclosed
US-7786330-B2 sulfonation, halogenation, deprotection, with 2-fluorophenol as starting material; industrial scale ASAHI GLASS COMPANY, LIMITED (JP) 2010-08-31 — — US disclosed
US-20090227817-A1 Process for producing 1,2-dialkoxy-3-fluorobenzene ASAHI GLASS COMPANY, LIMITED 2009-09-10 — — US disclosed
EP-2055692-A1 PROCESS FOR PRODUCING 1,2-DIALKOXY-3-FLUOROBENZENE Asahi Glass Co., Ltd. (JP) 2009-05-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227817-A1 Process for producing 1,2-dialkoxy-3-fluorobenzene HAAO, HDHD5, AFF2 SMN1; SMN2 4823/4885L3MBTL1 2854/4885TDP1 3515/4885
US-20100286451-A1 Process for producing 1,2-dialkoxy-3-fluorobenzene HAAO, HDHD5, AFF2 SMN1; SMN2 4823/4885L3MBTL1 2854/4885TDP1 3515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback